EBS vs PCAR · rev $390.4M vs P/E 25, rev $33.66B
Emergent Biosolutions Inc (EBS) versus PACCAR Inc (PCAR) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
PACCAR Inc (PCAR) is a farm & heavy construction machinery company listed on NASDAQ.
Latest reported EBS revenue for 2026-06-30 was $390.4M. Net income was -$173.4M. EBS currently screens at market cap $416.4M.
Latest reported PCAR revenue for 2024-12-31 was $33.66B. Net income was $4.16B. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
EBS currently screens at market cap $416.4M. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
Not investment advice. Open the EBS and PCAR stock pages for the full models.
Not investment advice.